AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.260
-0.010 (-0.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
AN2 Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Hold
Price Target
$3.50
Upside
+177.78%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $5 | Buy | Reiterates | $5 | +296.83% | Nov 19, 2024 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 18, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $6 → $3 | Buy | Maintains | $6 → $3 | +138.10% | Aug 9, 2024 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Jul 3, 2024 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $7 → $2 | Hold | Maintains | $7 → $2 | +58.73% | May 16, 2024 |
| JMP Securities | JMP Securities | Hold → Buy Upgrades $6 | Hold → Buy | Upgrades | $6 | +376.19% | Apr 2, 2024 |
| Oppenheimer | Oppenheimer | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 1, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $23 → $7 | Buy → Hold | Downgrades | $23 → $7 | +455.56% | Feb 13, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $25 → $7 | Buy → Hold | Downgrades | $25 → $7 | +455.56% | Feb 12, 2024 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 12, 2024 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 12, 2024 |
| JMP Securities | JMP Securities | Buy Initiates $30 | Buy | Initiates | $30 | +2,280.95% | Jan 4, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $20 → $24 | Buy | Maintains | $20 → $24 | +1,804.76% | Mar 30, 2023 |
| SVB Leerink | SVB Leerink | Buy Maintains $27 → $25 | Buy | Maintains | $27 → $25 | +1,884.13% | Nov 14, 2022 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $25 | Buy | Initiates | $25 | +1,884.13% | Apr 19, 2022 |
| Oppenheimer | Oppenheimer | Buy Initiates $22 | Buy | Initiates | $22 | +1,646.03% | Apr 19, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.